VanEck Associates’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$268K Hold
20,354
﹤0.01% 1277
2026
Q1
$300K Buy
20,354
+934
+5% +$15.3K ﹤0.01% 1231
2025
Q4
$250K Buy
19,420
+1,638
+9% +$17.3K ﹤0.01% 1260
2025
Q3
$150K Buy
17,782
+2,204
+14% +$20.8K ﹤0.01% 1299
2025
Q2
$134K Buy
15,578
+3,116
+25% +$23.1K ﹤0.01% 1283
2025
Q1
$108K Buy
12,462
+1,936
+18% +$13.8K ﹤0.01% 1275
2024
Q4
$70K Buy
10,526
+5,524
+110% +$41K ﹤0.01% 1284
2024
Q3
$35K Sell
5,002
-3,682
-42% -$33.9K ﹤0.01% 1290
2024
Q2
$90K Buy
8,684
+808
+10% +$8.07K ﹤0.01% 1258
2024
Q1
$79K Buy
7,876
+420
+6% +$4.51K ﹤0.01% 1247
2023
Q4
$114K Sell
7,456
-266
-3% -$3.67K ﹤0.01% 1224
2023
Q3
$108K Buy
7,722
+72
+0.9% +$1.09K ﹤0.01% 1225
2023
Q2
$101K Sell
7,650
-943
-11% -$12.8K ﹤0.01% 1239
2023
Q1
$138K Buy
8,593
+1,357
+19% +$24K ﹤0.01% 1207
2022
Q4
$108K Buy
7,236
+630
+10% +$11K ﹤0.01% 1236
2022
Q3
$131K Buy
+6,606
New +$164K ﹤0.01% 1128

Other funds holding HLF

VanEck Associates's HLF Position: Q2 2026 in Review

VanEck Associates held its Herbalife (HLF) position steady in Q2 2026 at 20,354 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #1277.

VanEck Associates first reported a position in HLF in Q3 2022 and has held it in 16 quarters since. The position peaked at $300K in Q1 2026. 234 funds tracked by Wall St. Rank hold HLF as of Q2 2026.

  • VanEck Associates held 20,354 shares of Herbalife worth $268K as of Q2 2026.
  • VanEck Associates left its Herbalife share count unchanged in Q2 2026.
  • Herbalife made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1277 holding.
  • VanEck Associates first reported a position in Herbalife in Q3 2022 and has held it in 16 quarters since.
  • VanEck Associates's Herbalife position peaked at $300K in Q1 2026.
  • 234 funds tracked by Wall St. Rank held Herbalife as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.